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The clinical research programs in amyloidosis and sickle cell disease described in
this issue exemplify a continuum of bench-tO-bedside research in which a dynamic
and productive interchange between basic scientists and clinical investigators trims
the time from concept to capsule. The breast cancer research program now under
way illustrates how, With motivation and leadership’the faculty can mobilize to
address important research problems. Only a few years after start-uP’the initiative
in women’s health has recruited more than two dozen investigators in a bold,
broad, and comprehensive investigation of the causes and treatment of breast can-
cer. on an even larger scale, SeVeral initiatives in health services research permit
population-SCale studies to examine issues of access’quality of care, OutCOmeS’and
costs of care. Inndeavors ,We COntmue tO enJOy StrOngacademic a d
research links with the滝terans Adminis使ation medical centers.
Increasingly, the School,s research enterprise attracts students, and we血od that
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Bridging the gap between research and patient care
D詣葦詰Y
affect a patient’s health in years to
come and whether a drug therapy
can activate long-dormant genes are
but a few of the questions regularly
answered by clinician-SCientists
at Boston University SchooI of
Medicine (BUSM). Bridging the gap
between basic researchers working
behind laboratory doors and physi-
cians practicing on the front lines
of disease management, BUSM’s
impressive cadre of clinical researchers
has made remarkable strides in creat-
ing effective therapies for disease and
in buttressing the epidemioIogical
evidence for those therapies.
Clinical research is often referred
to as “bench-tO-bedside’’practice. It
combines the meticulous and rigor-
ous principles necessary in basic
research with the hands-On emPathy
of practicing clinicians. At BUSM,
these seemingly disparate, yet ulti-
mately complementary, aPPrOaChes
among its various clinical research
teams-three of which are profiled
here - are Cultivated every day.
Debomh Cotton, MD, MPH
C1inical research is an integralpart of BUSM’s mission・ As
understanding of basic cell functions
grows and new therapleS become
reality, it becomes essential to trans-
late these advances into patient care.
However, bridging the gap between
laboratory work and effective therapy
can only be accomplished via safe,
careful clinical trials and rigorous
epidemiological analyses.
Tb support this mission and con-
tinue its widely established reputation
as a center of interdisciplinary coop-
eration, BUSM, tOgether with Boston
Medical Center (BMC), formally
established the Office of Clinical
Research (OCR), under the direction
of Deborah J. Co請On, MD, MPH, in
July 1998. Cotton, a 1976 BUSM
graduate who was recruited from the
Massachusetts General Hospital, is a
world-renOWned researcher in the
area of the clinical epidemioIogy of
AIDS and HIV/AIDS in women.
Cotton, PrOfessor of medicine, ePl-
demioIogy and biostatistics, and assis-
tant provost of the medical campus,
is the for皿er chair of the Antiviral
Advisory Committee of the Food and
Drug Administration, Which reviews
drug licenses for AIDS treatments in
the United States, and is a long-
standing member of the Board of
H alth Services Policy at the Institute
of Med cine.
Cotton se s the OCR mission as
threefold. “First, We need to enhance
the infrastructure of the medical
campus to promote the most e鮒cient
conduct of clinical research. W7e need
to re-engmeer eVerything from grant
administration to research plaming
to atient recruitment),, says Cotton.
“We must aggressively seek new din-
ical research opportunities, including
incubating new ideas with the help of
the Community脆chnoIogy Fund -
Boston University’s in-house venture
capital group-tO aSSist clinical
investigators in developing novel
thera leS, teStS, and medical devices.’’
Finally, Cotton wants the OCR
to respond t  a national shortage of
physician-reSearChers. “ Studies have
now conclusively documented this
critical shortage,’’says Cotton, “and
we’re com itted to developing new
PrOgramS tO integrate trammg ln
clinical investigation into all stages of
medical education葛from undergrad-
uate through residency and specialty
fdlowships. ,,
Cotton emphasizes that the
OCR is situated in a superb research
environment. “BUMC ranks twenti-
eth in the nation in receipt of federal
funding,,, she says. “In the 1998
fiscal yeaちWe reCeived more than
$100 million in research funding
from federal and other sources.,,
BUMC has hosted an NIH-funded
general Clinical Research Center for
thirty years, and Boston University
is known for a large number of
National Centers of Exce11ence. It is
Within this Iong-Standing framework
Of excellence that the accomplish-
ments of many unlque reSearCh teams
have grown and developed.
Although the three teams pro-
胤ed here are treating very different
disease conditions葛amyloidosis,
Sickle cell disease, and breast can-
Cer-they have much in common: a
multidisciplinary approach, the high-
est stafidards of professional support
Within the team and among the disci-
Plines, and, above all else, SuPreme
dedication to patient care.
0詰器霊豊嵩
found in the hallways of the Center
for Cancer Care and Blood Disorders
belie the aggressive treatment many
Of its patients undergo喜Particularly
those patients being treated for amy-
loidosis. This group of diseases, in
Which one or more of the body,s
Organ SyStemS aCCumulate abnormal
PrOtein deposits, is so rare that most
Patients diagnosed with it have little
Or nO information about its pathol-
Ogy Or treatment. It can also be a
ba鮒ing diagnosis for physicians to
make, because the various forms of
the disease affect a variety of the
body’s systems.
Martha SkinneちMD, PrOfessor
of medicine and staff member in
the Department of RheumatoIogy
at BUMC, is the director of the
Amyloid廿eatment and Research
Program, One Of the largest and most
SuCCeSSful amyloid treatment centers
in the world, and has been with
the program since its earliest days.
Skimer; a rheumatoIogist by train-
mg, first became involved with the
PrOgram When she worked under the
direction of Alan S. Cohen, MD, ,52,
Cohen, the program,s foundeち
first director; and former head of the
RheumatoIogy Department, WaS inter-
ested in determining what proteins
We  reSPOnSible for amyloidosis.
Skinner began work on developing
a me hod for isolating the proteins
from ti sue, and subsequently per-
form d the initial biochemistry. As
Skimer pomtS Out, “I wasn,t trained
as a biochemist, but was very lucky
to have tremendous support from the
Biochemis ry Department to teach
me the techniques necessary to
accomplish this work.,,
丁reatment and research
Becaus  the program combines the
b s  of basic research with ongoing
tre ment, Skimer and her colleagues
have seen tremendous growth in
both the treatment potential for
Patients and the Amyloid Program
itself, Which cared for more than 300
Patients in 1998.
“Wt’ve bee  at the forefront
Of amyloid research and treatment
for mo e than twenty」uve years,・・
Skinner adds. ``What makes this
d partment so successful is the
teamwork: teamWOrk among our
researchers, teamWOrk in carmg for
Our Patients. We’ve been able to cre-
ate a treatment program because of
this careful coordination of research
and treatment- and through the
assiduous follow-uP and study of the
approaches we,ve developed.,,
The clinical research component
Of the Amyloid Tieatment and
Research Program is essential. “Fre-
quently, by the time our patients get
to us, they are very, Very ill,,, admits
SkimeL ``Wちcan,t afford not to con_
Sider the immediate benefits of our
basic research. ,,
Combining §ki=s
The interdisciplinary approach of
the amyloid team’s clinician-
researchers has led to significant
advances in the use of chemotherapy
(to destroy plasma cells producing
amyloid proteins), and the relatively
novel program of stem cell rescue
for treatment of prlmary amyloido-
sis-the most common form of the
disease. “The stem cell rescue pro-
gram is the front-runner for patients
who are well enough to undergo the
procedure,’’says Skimer. ``We were
looking at a group of patients who
were getting better with oral
chemotherapy, but many of them
were so sick that they literally did
not have time for the oral therapy to
disrupt the formation of the abnor-
mal plasma protein. We changed our
approach to deliver the drug intra-
venously to obtain a more expedient
and readily available effect.’’
Concurrently, Stem Cell rescue
was being used for treatment of a
variety of other blood disorders.
“Our hematoIogists proposed that
stem cell rescue would be appropri-
ate for those patients who could tol-
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erate it,’’she says. As a result, a neW,
highly ffectiv  treatment has become
available for many prlmary amyloid
Patients.
Expanding the scope of treatment
The t eatments developed by the
Amyloid P ogram are not limited to
prlmary amyloidosis. Research on
secondary and hereditary amyloidosis
is also being conducted at the center.
Secondary amyloidosis results
rom a chronic infection or inflam-
matory condition, SuCh as rheuma-
toid ar hritis, OSteOmyelitis, Or
fam lial Mediterranean fever. Tieat-
ment and research for secondary
amyloidosis concentrate on manag-
ing the nderlying cause of the
condition. As the infectious and
inflammatory diseases responsible
for causing secondary amyloidosis
are eliminated, the disease has
b come increasingly uncommon in
the Westem Hemisphere.
Understanding how the protein
is produced has resulted in successful
treatment of hereditary amyloidosis.
“In this type of condition, We have
established that the abnormal Protein
production takes place in the liveす’
says Skimer; “SO We Were able to
pioneer liver transplants in hereditary
amyloidosis patients-the only cur-
rently available treatment・ ’’
The commitment to team effort
shows in the progress the Amyloid
Ti.eatment and Research Program has
made in a relatively short period of
ime.代I started this work before it
was known that primary amyloid
origmateS in the bone marrow,’’says
Ski ne . “V(7e,ve made incredible
strides, and it is because we have the
unlque qualities found in a clinical
research center. ’’
F蒜譜議書霊宝f
researcher Susan P Perrine, MD, Who
has devoted a significant portion of
her career to developing safe, long-
term, and effective treatments for
sickle cell disease and thalassemia.
Perrine is the director of BUMC,s
Hemoglo binop athy Thalassemia
Research Unit, and associate professor
Of medicine, Pediatrics, and pharma-
COIogy. She is also an associate profes-
SOr Of experimental therapeutics.
A鮒icting millions worldwide,
this group of blood disorders is
among the most common of the
genetic diseases. AIso referred to as
beta-hemoglobinopathies or the beta-
thalassemias, the conditions result
from mutations in the adult beta_
globin gene, Or a region controlling
the expression of that gene・
Though both diseases are geneti-
Cally linked, they differ in their pre-
Sentation. Normally) OXygen-Carrymg
red blood cells are doughnut-Shaped
and flexible. The flexibility allows
them to pass through arterioles and
CaPillaries. Howeveちin sickle ce11
disease, a genetic mutation causes
red blood cells to become stiff and
curved臆1ike a sickle - after deliver-
mg OXygen tO the peripheral tissues.
Unlike their healthy counterparts,
these cells camot easily pass through
arterioles and capillaries, and may
obstruct them.
While sickle cell disease is the
result of a genetic mutation that
affects the shape of red blood cells,
thalassemia is related to the rapid
death of these cells. The bone mar-
row produces massive quantities of
red blood cells that die relatively
quickly, leavmg the patient extremely
anemic and usually dependent upon
blood transfusions to live.
Tuming on dormant genes
Pe rine, along with Douglas Falleち
MD, PhD, director of BUMC,s
Ca cer CenteちPrOfessor of medicine,
biochemistry and pediatrics, and
r ea ch professor of pathoIogy and
laboratory medicine, has been work-
ing on ways to reactivate a fetal
hemoglobin gene as a long-term
tr atment for sickle cell and tha-
lassemia. According to Perrine, it
was well known that infants bom
With both diseases did not show any
Signs or symptoms of disease until
after they were about four to six
mon hs d. No signs of disease or
illness existed Jn utero. “It is also
Well known that fetal hemoglobin
is switched off at this time. In rare
CaSeS, Wh n f tal hemoglobin contin-
ues to be expressed (approximately
20 percent of cases), the disease does
not cause problems,’’says耽rrine.
Ext nsive work in the laboratory and
in rare cases has subsequently shown
th t fetal hemoglobin prevents red
blood cells from sickling.
Perrine and Faller have researched
a substance that could reactivate the
dormant fet l gene and could be used
Safely n children. Perrine,s work led
to the discovery that when a metabo-
1ite (similar to the natural fatty acid
butyrat ) is resent in high levels in
developmg infants, it prevents fetal
hemoglobin from “switching off. ,,
This in tum led to the development
Of new drugs and new clinical trials
to carefully evaluate their effects. As
a result, Perrine and Faller are cur-
rently working on several multicen-
teちintemational Phase II clinical
trials that involve regulating genes
With drugs to potentially benefit sickle
Cell disease and beta-thalassemia,
as we11 as a specific type of lym-
Phoma. The goals of these current
trials are to deter皿ine if specific ther-
apleS Can heal refractory leg ulcers in
SzクSan Peγrlne, MD
Patients with sickle cell disease,
increase red blood cell counts and
eliminate blood transfusions in beta-
thalasse ia, and cure patients of
usua11y fatal Epstein-Barr virus-
associat d malignancies.
A recently concluded trial exam-
ined the effect of pulsed butyrate
therapy in sickle cell patients. Accor-
ding to Perrine, “In nine out of
eleven adult patients wi血severe sickle
Cell, a regimen of pulsed butyrate
rea tivated the fetal hemoglobin gene
to the necessary level of 20 percent
Or mOre. In reated subjects, the
number of days of hospitalization for
Pam CrlSeS aSSOCiated with sickle cell
dis ase decreased by 75 percent-
from eighty days per year to nineteen
days per year. ’’
Breast cancer may be a disease withwhich clinicians and the lay public
have more familiarity than they do
with the beta-hemoglobinopathies or
amyloidosis; however; it is no less
challengmg for those attempting to
find preventive and curative therapies.
Maureen T Kavanah, MD, aSSOCiate
professor of surgery, and Marianne
Prout, MD, aSSOCiate professor of pub-
1ic health and medicine, and assistant
professor of surgery’have seen their
work benefit from the integrated, mul-
tidisciplinary approach central to
BUSM,s mission.
That mission was particularly
evident to Kavanah, Who completed
the two-year Surgical oncoIogy fel-
lowship at BUSM in 1981-One Of
the original surgical oncoIogy train-
mg PrOgramS in the United States-
under the direction of Peter J. Mozden,
MD, PrOfessor emeritus of surgery.
As one of the first women trained in
surgical oncoIogy, Kavanah empha-
sizes, “The members of the Section
of Surgical OncoIogy were highly
ski11ed surgeons and oncologists who
also had the warmth and compassion
necessary to help patients and their
families deal with the complexities
of cancer diagnosis, treatment, and
follow-uP Care.’’During the program,
Kavanah also received training in
multidisciplinary approaches to care,
including medical oncoIogy and radi-
ation oncoIogy. At the basis of each
treatment plan was a thorough
analysis of the underlying pathoIogy
and radioIogic studies.
T坊e 諦ensiひe clinical
reseaγCh conducted bγ
Kaひamh, Prouちand iheir
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A new era of preventive oncoIogy
The comprehensive approach to
treatment clearly evident in
Kavanah,s fellowship training has
contributed to the clinical research
she and Prout conduct. αWe work
closely with our colleagues in an
integrated, multidisciplinary
metho ,,, says Kavanah. “We have
also had a long experience participat-
ing in National Cooperative Clinical
丑ials, fou ded by the National
C ncer Institute. ’’
T extensive clinical research
conducted by Kavanah, Prout, and
their colleagues has shed the first
light on a new era in breast cancer
chemoprevention. As chemopreven-
tion has been successful in other
areas of medicine, SO nOW it is occur-
ring within oncoIogy. Kavanah is
hopeful about the future of this pre-
ventive approach. ``We know that a
l t of resea ch effort and attention
will continue in this direction as
we c ncomitantly move toward
treating patients with diagnosed
malignancy,’’she says.
丁bward that end, Kavanah’s and
Prout’s association with the National
Surgical Adjuvant Breast and Bowel
Program (NSABP) center at BUSM
has been crucial. The NSABI〕 a coop-
rative group formed in 1971 to
conduct clinical trials in breast and
coIorectal cancer research, is funded
prlmarily by the National Cancer
Institute (NCI). BUSM was first
designated a NSABP site in 1971.
Kavanah was the protocoI chaiman
of the NSABP,s Breast Cancer
Prevention Ti-ial (BCPT). “The NCI
recently termed this the `hallmark
study of the century’as far as breast
cancer prevention is concemed,’’says
Kavanah. In addition, Kavanah was
made national chairman of the BCPT
in 1994; later that yeaちProut took
over the role of prlnCipal investigator.
Owing to the scrupulously careful
manner in which that trial was con-
ducted, BUSM’s NSABP center has
been selected to participate in the
upcoming Study of Tamoxifen and
Raloxifene (STAR) triaL This twelve-
y aちmulticenter clinical trial wi11
study the effects of tamoxifen and
raloxifene on postmenopausal women
considered at risk for breast cancer.
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Supporting changes in practice and policy
H盈蒜聖霊
a university clinic than a unlVerSity
department. However; this relatively
new area of study has occupied
the time and attention of many
researchers at Boston University
SchooI of Medicine (BUSM) and the
Boston University SchooI of Public
Health (SPH).
Health services is a growmg field
aimed at using both traditional, basic
methodoIogies and nontraditional
methods to answer a broad range of
questions about the practice, POlicy,
financmg, and delivery of medicine.
Investigators studying the frold look at
a complex web of issues ranging from
macroeconomic concems about how
govemments approach health care
financing to front-1ine clinical prob-
lems, including ever-Shrinking patient
appointment lengths and concems
about the safety of certain drugs.
BUSM, in conjunction with the
SPH, has been at the forefront of this
unlque and far-reaChing field since the
early 1970s. Faculty and clinicians
involved wi血this research include
PraCtlClng Prlmary Care Physicians,
Ⅵterans Administration (VA) research
Staff, POlicy and legal analysts, ePi-
demioIogists, and biostatisticians.
しeading the way in heaIth services
Mark Prashker, MD, MPH, is associ-
ate professor of medicine and public
health at BUSM, and chair of the SPH
Health Services Department. In addi-
tion to overseeing the
department and its staff
Of thirty-Six full- and part-
time faculty, Prashker also
Ma巌Pms履eちMD, MPH
heads the Center for Health Quality
Outcomes Economic Research, a VA
Field Service Program.
The Health Services Department,s
COurSe Of study offers students oppor葛
tunities for field practice experience,
as well as directed research projects
in long-term Care’administration,
Public-Private sector agencies, and
matemal and child health. Tiainmg
Students for this incredibly diverse
field is more important now than
ever before.
According to Prashkeち“This is
really the golden age of health ser-
Vices research, ironically due in part
to the failed Clinton health care
refom proposal.,, Although the
attempt to reform health care deliv-
ery, POlicy, and practice on a national
level did not succeed, Prashker does
See the attempt as spumng both the
funding and interest in this area of
Study. αConsider that although we
did not have a drastic overhaul of the
health care system, the public and
Private sectors have moved forward
On a number of the issues surround_
ing the ideas proposed in the Clinton
reform package. One great exa皿ple
is the VA-they’ve consolidated
from 128 hospitals into 22 integrated
delivery systems, ,, says Prashker.
In addition, reCent trends
toward the consolidation of the pri-
Vate health care industry will also
result in significant changes in both
the way patients access care and the
mamer in which血at care is provided.
“With the mega-mergerS OCCumng in
health care insurance, PeOPle are
actually facing what they claimed
would be the downfall of health care
refom: reduced choices,,, comments
Prashker. It is precisely those kinds of
COnSOlidations - and the resulting
effects on patient and provider-
that health services researchers study.
Howeveちthey examine血ese macro-
trends (and o血er microscale effects) in
hopes of gleanmg valuable clues about
how similar decisions might affect
StruCture, Patient care, Clinical
responses, treatment decisions, and
Standards of care in other health care
Organizations.
Health services investigators,
though, are COnCemed with more
than simply understanding cause and
effect鵜they seek to provide clini-
Cians, POlicy-makers, and health care
administrators with tangible tooIs to
SuPPOrt aPPrOPriate and beneficial
Changes. “Ⅵ7e want to be certain that
the tooIs we provide are based on
SO皿d, logical, and methodically
appropriate reasoning based in valid
data,,, says Prashker. The programs
at BUSM and SPH rank among the
best in the United States in terms of
assessing health care quality, POlicy,
economics, management, and issues
associated with access to care. “Wな’re
conducting very cutting-edge work in
terms of developing the methodologi-
cal framework for addressing health
services questions,” Prashker adds.
Prashker also emphasizes that
the work is not limited to analysis
of existing data. “We also do a great
deal of prlmary data collection in
large cohorts of patients.’’The VA
is one large patient cohort that pro-
vides a substantial population that
Prashker,s colleagues can use to col-
lect such invaluable primary data.
“The relationship between SPH,
BUSM, and the VA network is sym-
biotic,,, Prashker emphasizes, “and
we,re very aware of our good fortune
in having that kind of relationship.’’
Impact臆Of heaIth service§
Addressing the direct impact of
health services research on his clini-
cal practice is Mark Moskowitz,
MD, PrOfessor of medicine and pub-
1ic health at BUSM, and chief of the
Section of General Intemal Medicine
at BUMC.
Like Prashker; Moskowitz has
conducted primary data collection,
but concentrates more frequently on
the use of large administrative data-
bases. His belief is that health ser-
vices applications should be used to
support changes implemented in vari-
ous aspects of medical care. “We
need a logical, methodical approach
to the changes we decide to make.
W7e should not simply base change on
one physician’s notion that some-
thing is a good idea. Health services
data a1low us to use a very scientific
methodoIogy to support change,”
says Moskowitz.
Moskowitz and his colleagues
have made liberal use of a unique
outgrowth of health care informatics
in the United States: the accumulation
of, and access to, large administrative
databases. Within that framework,
they have focused on three very spe-
cific issues: aCCeSS tO Care, quality of
care, and outcomes of treatment.
The idea that nonbasic, nOnClinica1
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res arch will effect change in that tri-
umvirate may appear unusual to a
“traditional,, basic researcher; how-
eveちMoskowitz pomtS tO SeVera1
1arge databases as key to understand-
ing the enormous value inherent in
this kind of approach・
``In 1997, there were 39 million
people enrolled in Medicare, 37 mil-
1ion in Medicaid,” says Moskowitz,
“and f hose patients, We have
access to data for about 700,000
cases of congestive heart failure,
450,000 cases of pneumonia, and
370,000 cases of chronic obstructive
pulmonary disease.’’
Moskowitz and his colleagues
also identified the VA database and
other Health Care Finance Adminis-
tration databases as equally rich
veins of material to be mined for
health services analyses.
Ma巌Mo諒ouノit之, MD
TangibIe impact on practice
There is a growing body of clear evi-
dence that these very large data collec-
tions will continue to result in studies
that will have a tangible impact on
clinical practice. The VA population
was recently the subject of a study
Moskowitz conducted in cooperation
with Daniel Berlowitz, MD, MPH,
associate director of the VA Center for
Health Quality, Outcomes and
Economic Research at the Bedford VA
Medical Centeちand an associate pro-
fessor of medicine at BUSM.
The study, Published in the
December 31, 1998, issue of The
Neu′ England ]ourml of Medicine,
provided some interesting findings
about the management of hyperten-
sion. It determined that physicians
failed to adequately control hyper-
tension in many patients even though
excellent medications are available to
achiev  such control. Access to care
and cost of care were both ruled out
as impediments to treatment・ Because
so many dinical trials have proven
the efficacy of treating hypertension
to prevent cardiovascular disease and
stroke, the study findings are signifi-
cant in their ca11 to physicians to
reassess their treatment for, and man-
agement of, hypertensive patients.
It is precisely this practical appli-
cation, derived from health services
research, that Moskowitz and
Prashker believe must become a vital
part of medicine -Particularly when
there is sound evidence that preven-
tion can dramatica11y alter disease
pathology and outcomes. In tum,
costs for tertiary care can be dramat-
ically reduced when prevention is so
dearly proven to be effective. “We
can all agree that hypertension is a
condition that needs to be treated,
and that the failure to do so results
in serious consequences,’’says
Moskowitz. “Yet our study clearly
demonstrates that physicians are not
aggressively treating hypertension or
taking the simple, neCeSSary StePS tO
reduce high blood pressure.’’
Arthrjtis research
The accuracy of the recently com-
Pleted Framingham Heart Study
(FHS) has been so well established
that it continues to be used exten-
Sively by BUSM researchers to pro-
Vide very reliable conclusions about a
number of health concems. David
Felson, MD, MPH, PrOfessor of med-
icine, ePidemioIogy and biostatistics,
WOuld not necessarily refer to the
work he conducts as αhealth ser-
Vices’’; howeveちhis is the kind of
CIose, Careful analysis of existing
data that is the essence of appropri-
ately applied health services work.
As director of the NIH-funded
Multipurpose Arthritis Center, Felson
has had the opportunity to work
With Framingham data with the goal
Of developing preventive measures
for this debilitating condition.
His recent study, COnducted in
collaboration with BU researcher
Christine Chaisson, MPH, eXamined
the correlation between grlP Strength
in the proximal hand joints (metacar-
POPhalangeal joints and thumb base)
and the development of osteoarthri-
tis. According to Chaisson, this is the
first study to examine the relation-
Ship of osteoarthritis and grip
Strength in different types of hand
joints. “The forces at the jomt and
the frequency those forces are
applied is new territory in arthritis
reseaich,’’notes Chaisson. “Ⅵ7e,ve
had some studies about hand biome-
Chanics that show force along the
joints, but no one has evaluated this
Particular association before. ,,
The fact that Felson and his col-
leagues can conduct research pro-
grams that look at such previously
unexamined connections is intimately
tied to one of the primary goals of
health services research: effecting
Change in outcomes based on solid
evidence that practical preventive
measures do exist and should be
implemented, and that via that
implementation, tertiary care costs
would be greatly reduced.
Drug epidemioIogy
While access to large administrative
data sources provides health services
researchers with an exIStmg POOI of
infomation for analysis, Other con-
tributions to health services data are
being made at the SIone EpidemioIogy
Unit (SEU). Founded in 1975 at
BUSM, SEU is a multidisciplinary,
intemationally recognized research
group with specialists in epidemiol-
Ogy, adult and pediatric medicine,
nursing, Phamacy, biostatistics, and
COmPuter SCience.
Currently under the direction of
Allen Mitchell, MD, PrOfessor of
Pediatrics, ePidemioIogy and biosta-
tistics, the SEU has been invoIved
With a number of groundbreaking
Studies. “The work here is a comple-
mentary approach to the work
being conducted by health services
researchers at BUSM,’’says Mitchell.
The mission of the SEU is to
identify and quantify the occurrence
Of diseases caused by medications and
lifes yles and to provide estimates of
the risks and afety of drugs in rela-
tion o specif c diseases. According to
Samuel Shapiro, MBBCh, director
emeritus of the SEU, and professor of
epidemiology and biostatistics, “Ⅵ
test hypotheses and try to discover
PreViously unsuspected associations
involving drugs. ’’Proving out those
h potheses requires careful and assid-
uous epid mioIogical work. “We
m st be constantly vigilant against
erroちand against the temptation to
make inferences where none exist,,,
he adds.
Prog ams at SEU
The many programs currently under-
Way at the SEU have the potential to
PrOVide health service investigators
and front-1ine clinicians with infor〇
㌢tion that can be used to identify
mterV ntions, both on a policy level
and in daily clinical practice, that can
reduce the burden of disease caused
by medication  and lifestyles. The
tangential relationships with which
health services researchers are con_
cemed are inherent in some of the
l rge case-COntrOl and cohort studies
SEU is overse mg.
One such program is the birth
defects case-COntrOI study. This ongo-
mg Study h s accumulated informa-
tion on more than 18,000 infants
bom with birth defects in more than
e ghty institutions in Boston, Phila-
delphia, and lbronto. The program is
designed to provide a national data
sourc  for both the identification of
PreViously unsuspected associations
and the testing of hypotheses relating
environmental agents - Particularly
medications-tO birth defects. This
rese rch ha  supported the now-
accepted observation that folic acid
intake in pregnant wo皿en can
d crease the likelihood of an infant
developing spina b誼da by 30 to 40
PerCent.
Another current study, Which
Will eventually provide investigators
with an invaluable collection of data,
is the Black Wbmen’s Health Study.
This udy is ollowing more than
65,000 Af ican-American women to
as ess risk factors for heart disease,
anCerS, and other major illnesses.
It will also provide information on
demographic factors, rePrOductive
and contraceptive histories, Clgarette
and alcohol use, Physical activity,
height, Weight, and use of ceftain
medications.
Other r search programs at
SEU have investigated the effects of
Cigarette smoking, alcohol, and oral
CO traCeP ives on cardiac health and
Certain cancers in women; Pre but
Serious adverse effects of ibuprofen
in children; and the effectiveness of
health promotion campaigns designed
o modify p rents’behaviors to
reduce the risk of sudden infant death
Syndrome. Health services investiga-
tors may be able to pose difficult
questions based on the data gathered
by SEU, and if previous efforts shown
by SPH and BUSM researchers are
any indication of success, they will
COme uP With some valuable, Practi-
Cal, and applicable answers.
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New outpat-ent fac吊ty and quadrangIe to connect campuses
B器l豊諾豊S
construct a new ambulatory care
facility to help maintain and improve
the quality of care provided to
patients for many years to come.
The new facility is the current
focus of a BMC master plan pro〕eCt,
which wi11 create new space for the
hospital, mOdemize existing facilities,
and remove some of the unusable
vacant buildings that currently form a
physical barrier in the middle of the
BMC campus. Construction of the
new ambulatory care facility is slated
to begin in July 1999, Wi血a projected
completion date of March 2001.
The master plan is progressive in
its vision to unify the medical cam-
pus by creating a central campus
quadrangle and integrating existing
facilities with a new ambulatory care
facility. The plan is respectful of the
neighborhood,s past in re-eStablishing
an important urban design relation-
ship with the adjoimng South End
Landmark District. “Boston,s South
End has a rich and vibrant architec-
tural history,’’says Elaine Ullian,
BMC president and CEO, and associ-
ate professor of public health.
AγChiタeci:s 7,endeγing
of fhe neuノambulatoγy
caγe伽iliタ)l
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“we are working very dosely with
the local historical associations and
prese vation experts to retain the
grandeur and architectural integrity
of our neighborhood.’’
The Administration Building,
located between the BCD and FGH
buildings on Harrison Avenue, Will
be demolished to make way for the
ate-Of-the-art ambulatory care facil-
ity. The new construction will pro-
vide much-needed additional space
for ambulatory and critical care, the
areas of largest growth at BMC"
Renovations to the BCD and
FGH buildings also play important
roles in the new plan. BCD has been
vacant for twenty years and exterior
stabil z tion and facade restoration,
along with various interior repalrS,
are needed. It is envisioned that the
space will be us d for clinics and
doctors’offices.
The proposal also calls for the
demoli  of the Thomdike, MRI,
and Sears buildings lining East
Concord Street. With the removal of
these buildings, the various existing
smal  open spaces on each of the sep-
arate campuses will be combined to
form a centra  quadrangle.
“unlike many urban medical cen-
ters, Which have little real estate space
for new projects and campus develop-
ment, Boston University Medical
Campus (BUMC) has sixteen acres of
available land on the BioSquare site
and a number of existing campus
build ngs, ll of which provide us
with a wide array of options for
development and renovation,’’
says Rich rd Tbwle, Vice president,
Administrative Services, Boston
Univ rsity. “As a result, BUMC is
well positioned to meet its space
needs through the next decade.’’
BIOSQUARE PROGRESS
REPORT
BjoSquare“s cu「rent master pian provides
for the development of l.2 m冊on square
feet of buiiding space on eight acres of
iand aIong Aibany Street・丁he pian
三甲言includes four research/office buiidings,
a l ,OOO-SPaCe Parking garage, 5,600
Square feet of reta= space, and a 230-
room hoteI,
丁he second BioSquare building, tO be
known as Evans BiomedjcaI Research
Center, is currentiy under construction
and scheduIed to be compIeted in
」anuary 2000・ in additjon to housing
the Evans Medicai Foundation at Boston
Medical Center (BMC), the Evans
Biomedicai Research Center w川be the
new home of Oncogene, inc○○ a Iife-
SCiences company based in San Diego,
Later this spring, Unjversity Associates-
a joint venture invoIvjng Boston Unjversity
and BMC-W紺fiie an amended master
Pian for BioSquare with the Boston Rede-
Velopment Authority,丁he amended
ma§ter PIan w紺add approximately l"3
m冊on square feet of buii
Of land to
ParCel purchased
earlier and from land
reallgnment Of the N
Avenue/Route 93
箆　　　　　　か
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MedicaI education shifts from inpatient to outpatient settings
It used to be that medical schooISt d nts primarily tra ned by see-
mg Patients and followmg attending
Physicians in large teaching hospitals.
These days medical students are see-
mg Patients in a varlety Of settings-
COmmunity hospitals, doctors,
O鮒ces, neighborhood health centers,
and even patients’homes-aS Well
as in the traditional, tertiary care
hospital. Much of the reason for this
Change is the recent shift in patient
Care delivery from inpatient to more
OutPatient treatment, Which has had
a direct effect on the education of
medical students,
At Boston University School of
Medicine (BUSM), that shift is the
force behind the School,s decision to
form a鮒Iiations with several area
COmmunity hospitals and neighbor-
hood health centers, Which offer med-
ical s血dents the opportmity to see
Patients in outpatient settings. BUSM
has as its principal hospital affiliates
the Boston Medical Center and the
Boston ¥なterans Administration
Medical CenteL In addition, BUSM
now has affiliations wi血more than
twenty hospitals血roughout New
England and twelve neighborhood
health centers through血e Boston
HealthNet. Some of the larger
affiliated institutions indude Roger
Willi ms Medical Center in Rhode
Island; Bedford Veterans Adminis-
tration Hospital; Beverly Hospital;
and Brock on Hospital. In addition
to regional hospital affiliations,
BUSM also has limited affiliations
with several intemational medical
SChooIs and hospitals in Israel,
Ital , Hong Kong, Armenia, and
he Cameroons.
Adapting o changes in de音ivery
The en mous economic pressure
tha  health care institutions have
faced since the 1980s has profoundly
Changed the health care delivery sys-
t m, reSulting m an OngOmg trend to
have fewer patients admitted to hos-
Pitals for shorter lengths of stay.
Th s, in tum, tranSlates into an inpa-
駿恕搬療薮ゞt
tient population with greater severity
Of illness, Which is more skewed and
less representative of the general
POPulation. A larger percentage of
Patients who are admi筒ed to the hos-
Pital come in for specific procedures
that are relatively technical or for
treatment of end-Stage disease.
Another important health care
trend in recent years is the emergence
Of family medicine and primary care
as key specialty areas. BUSM’s grow-
ing affiliates network allows students
to see family medicine and primary
Care Patients in smaller community
hospitals, aS Well as in neighborhood
health centers and doctors, offices.
“Due to shifts in health care
trends, BUSM has adapted its med-
ical curr culum to meet the needs
Of tomorrow’s physicians, With a
Change from students following doc-
tors round the large teaching hospi-
tal to that of students being trained
in settings that offer primary care,,,
SayS John McCahan, MD, aSSOCiate
dean for Academic Affairs and
PrOfessor of family medicine. “Devel-
OPmg relatio ships with other hospi-
tals ensu es that BUSM students are
exposed o a greater selection of
Patients, eSPeCially in the primary
care field.,,
関∴わhn施Cahan, MD
In response to the growmg
importance of family medicine,
BUSM was the first medical school
in Boston to develop a ful皿edged
Department of Family Medicine.
Fomed in 1997’the department was
established as a specialty for trainmg
future physicians to care for patients
across the board’With an emphasis
On OutPatient care.
BUSM,s Department of Family
Medicine works cIosely with the
Boston HealthNet, a PartnerShip
between BUSM, Boston Medical
Centeちand twelve communi亡y health
CenterS, Which provides a broad
SPeCtrum Of primary health care ser-
Vices in neighborhood settings. The
HealthNet health centers are the pri-
mary teaching sites for most commu-
nity-based leammg for first- tO
fourth-year BUSM students in pedi-
atrics, intemal medicine, and family
medicine. Through grants from the
Robert Ⅵ)Od Johnson Foundation
and the Kellogg Foundation, these
CenterS have become a national
model for the development of aca-
demic community health centers.
“Boston HealthNet health cen_
ters provide students with an oppor-
tunity to leam about the communities
they are servmg, tO understand the
COmeCtion between environment and
health, and to understand multicul-
turalism and its comection to health
and health belief," comments Lisa
Levine, MPH, aSSOCiate director;
Generalist Physician Initiative of the
Center for Primary Care. “This expe-
rience allows students to really be
Part Of a community service organiza-
tion, and to follow through with con-
tinuity of care, Since students who
Start in a health center in the first
year of medical school usually stay
for the duration of their four years.,,
Clerkships p「ovide opportunjties
Another vehicle for medical students・
hands-On eXPerience, third-year
BUSM clerkships have evoIved in
recent years to give students more
traimng at newly a鮒Iiated institu置
tions. For example, third-year Stu-
dents currently serve in clerkships
at Roger Williams Medical Center
through the departments of Medicine
and Surgery.
A vital part of the Rhode Island
COmmunity for more than one hun-
dred years, Roger VAlliams is recog-
nized throughout the nation for
innovative programs in cancer
research and treatment, health care,
education, and medical research. It
has been a fully operational major
Clinical a鮒iate of BUSM since July
1997. The 220-bed acute care hospト
tal includes a 14-bed intensive care
unit and the only bone marrow
transplant unit in Rhode Island.
Since the a鮒iation, mOre than forty
Roger Williams physicians have been
appointed to faculty positions at
BUSM. Under the partnership,
BUSM students rotate through clini-
Cal clerkships at Roger Williams,
recelVmg instruction from the hospi-
tal faculty.
This yeaJ; Roger Williams was
named as one of the one hundred
best hospitals in the United States in
an annual study conducted by HCIA,
Inc., and William M・ MerceちInc., tO
establish industry benchmarks and
identify those institutions that have
demonstrated superior perfomance.
“Roger Williams is not a typical
COmmunity hospital because it has a
long academic tradition and a strong
teaching faculty," says Michael
Macko, MD, Site director for Medical
Clerkship and director of Continuing
Medical Education at Roger Williams,
and associate dinical professor of
medicine at BUSM. αWるget feedback
from BUSM students that they are
Very Satisfied with their clerkships at
Roger Williams because of the teach-
ing level and the high ratio of direct
mentormg Of students by faculty.,,
The expanding relationships
With BUSM affiliates also support
the School,s philosophical intent to
get students immediately involved
With practicing physicians from the
first day of medical school. The
School is more able to accommodate
those students who want exposure to
different types of patients in a variety
Of settings, aS We11 as other students
Who wish to have continuity with
Particular patients and facilities over
PrOlonged periods.
For Betsy Ciarimboli, a fourth-
year student anticipating a career in
PSyChiatry, rOtations in 。ommunity
hospitals such as the MetroWest
Medical Center, the Bedford VA,
Brockton Hospital, and Roger
Williams Medical Center have
broadened her exposure to patients
in sma11er facilities. It is a more per-
SOnal approach. Students are not
assigned to one doctoちbut rather
follow different attending physicians,
each treating his or her own patients.
``During my clerkship at Roger
Williams, I got to see patients alone
in their rooms, tO talk to them one-
On置One about what was happening to
them each day during their hospital
Stay, and really develop a relation-
Ship with them,’’says Ciarimboli.
“We saw general medicine patients,
ranging from pneumonia to end-
Stage CanCer, What I think of as
`bread and butter, medicine.,,
Another important affiliate
agreement is with the Family Practice
Residency Program at Beverly
Hospital, Which went into effect in
July 1998. As an academic partner in
family medicine, BUSM supports the
Family Practice Residency Program’s
faculty teaching and affords faculty
and residents more extensive research
and clinical opportunities than in the
PaSt. As part of the partnership,
Betsγ CiarimboIz
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“During mγ Clerたship at
Rogeγ Williams, J go"o
See Paiienis alone in Jheiγ
rooms, fo Ja施わJhem one○
○n-One about妙hat砂aS
haz准ening Jo Jhem each
day during Jheir ”ospiial
S青a)ち4nd γea妙′ det/elop 4
relationshiクのith them."
Betsy Ciarimboli
BUSM students serve clerkships in
family m dicine at the hospital and
its residency practice. Likewise, fam-
ily medicine physicians have received
faculty appointments at BUSM.
“Because we are a community-
based residency program, Student
interest in the Family Practice Center
s notably high,” says Mark Mengel,
MD, MPH, PrOgram director of the
Beverly Hospital Family Practice
Residency Program. “Through
the unique academic, Clinical, and
research programs at Boston
University SchooI of Medicine, We
look forward to training a new gen-
eration of family physicians who will
PrOVide high-quality family practice
SerVices to the residents of Beverly
and surrounding communities. ’’
A unique partner in the VA
One of the established affiliate rela-
tionships is the School’s association
with the Boston Veterans Admin-
istration (VA) Medical Center; a 250-
bed facility established in 1950. The
PartnerShip has served both institu-
tions well. BUSM,s affiliation with
the VA provides a faculty with
advanced knowledge and expertise
to partlCIPate in the care of veteran
Patients. Most of the veteran patients
who receive medical care at the VA
are elderly, and by and large suffer-
ing from advanced stages of disease.
The students, reSidents, and physi-
cians who work at the VA are often
Challenged by the complexity of these
cases, and leam a great deal about
PathophysioIogy and management.
The patients’ages and social situa-
tions are also important factors.
``Caring for these patients, eSPe-
Cially on the Surgical Service,
requires a great deal of consideration
of the risks versus the benefits of
intervention,” explains Nancy L.
Cante mo, MD, aSSOCiate professor
Of surgery and director of Surgical
Clerkships at BUSM, and associate
Chief of Surgery at the Boston VA
Medical Center. “As a result, trainees
PartlCIPate in the care of patients
with complex medical and social
PrOblems. Sharing faculty in patient
care, lectures, and conferences has
benefitted both institutions. ,,
Research is another area of
shared benefit for the VA and BUSM.
VA gra ts for both clinical and basic
SCience provide residents and stu-
dents with research opportunities.
Amually, the VA receives approxi-
mately $10 million in VA research
funds, and Boston VA principal
investigators receive another $4 mil-
1ion in funds from the NIH.
∝丁he VA h s a distinctive
Patient population,’’says Robert
Arbeit, MD, aSSOCiate chief of staff
for research at the Boston VA
Medical Centeちand professor of
medicine at BUSM. αResearch con-
ducted by VA pmCipal investigators
is targeted to problems and issues that
are relevant to this special patient
POPulation, and the result is血at it’s
focused on cutting-edge research in
basic and clinical science and health
SerVices that relate to the specific prob-
lems that are a challenge to the VA.,,
Trend toward outpatient care
The trend toward more outpatient
care is also evident at BUSM’s
Principal affiliate, Boston Medical
Center (BMC), Which itself is a vital
resource for leaming opportunities
for BUSM students. As the anchor
Patient-Care institution on BUSM,s
CamPuS, BMC is devoted to trainmg
future generations of health care pro-
fessionals. BMC operates thirty-eight
residency training programs with
more than/ 450 resident positions.
The central role that BMC plays
administratively and clinically is
i11ustrated in the fact that all clinical
chiefs of service at BUSM are also
clinical chiefs of service at BMC.
BMC has responded to the same
forces in health care that other insti-
tutions have by increasmg ltS OutPa-
tient service for patients in all
SPeCialties (see story on page 12).
“BUSM students are afforded an
OPPOrtumty tO eXPerience a variety
Of health care settings in placements
throughout the network of affiliates,
including BMC,’’says McCahan.
``This experience establishes some
SenSe that what they are leamlng lS
universal and is applicable in differ-
ent settings. It’s a much more enrich-
ing leaming experience. "
BMC and BUSM have developed
a long-Standing relationship in the
area of geriatrics, both in patient
Care and medical trainmg. BUSM is
One Of only a handful of medical
SChooIs that requlre a fourth-year
rotation in geriatrics with the unlque
feature of taking outpatient medi-
Cine, including medical students, tO
Patients in their homes, aS Well as to
those in Boston-area nurSing homes・
The home-Care PrOgram WaS eStab-
1 shed in 1875 and is the oldest con-
tinuously operating home medical
service in the United States.
Geriatric home and nursing
home patients have a wide range of
Chronic medical problems, SuCh as
diabetes, COngeStive heart failure,
dementia, urinary incontinence, and
immobility. Students are exposed to
a collaborative practice model that
includes physicians, nurSe CaSe man-
agers, nurSe PraCtitioners, and social
WOrkers with advanced training in
geriatrics.
Home visits give the geriatric
team an opportunity to evaluate
aspects of the patient’s care, both
medical and nonmedical, that may
not be apparent during a traditional
office visit. Medical students are
exposed to nonmedical issues that
include transportation problems,
insurance issues, and community
resources. Many of the students are
ble to,SPend an observational day
in the field with nurses from the
Visiting Nurse Association of Boston,
and most spend time at an adult day
health program.
Nursmg home care glVeS the
m dical students an opportunity to
c e or th  institutionalized frail
elderly who eed ongolng Prlmary
C , With additional exposure to
AIzheim r,s disease and other demen-
tias, Which re growmg at an eXPO-
nential rate.
Through the experience gained
during clerkships at affiliated institu-
tions, medical students gain access to
m r  diverse patients. Another added
benefit is that students gain exposure
to a larger group of faculty so that
the s uden -tO-faculty ratio is very
low Students often have an opportu-
nity to work one-On-One With an
ex erienced physician. “The undiag-
nosed, undi任erentiated patient is the
best teacher for students,,, explains
McCahan. “These types of patients
are most often seen in outpatient set-
tings. We need to be able to have our
Students work with patients before
they requlre the highly specialized
Care uSually given in a hospital.,,
Concluding a year-1ong celebrationof BUSM,s 150th amiversary,
the school honored Massachusetts
Senator Edward Kennedy last
November for his longtime commit-
ment to biomedical research and
medical education, aS We11 as his
overall support of Boston University
SchooI of Medicine.
At a ceremony held in the
Hiebert Lounge, Kemedy was pre-
sented with a special Sesquicentemial
Gold Medallion from Dean Aram
Chobanian and Boston University
President Jon Westling. “This is the
most fitting way I could imagme tO
dose our year-1ong sesqulCentemial
celebration-by awarding this medal
to Massachusetts’senior senatoち
with whom this campus has had such
a long-Standing, dose relationship,’’
Chobanian said. Kennedy also
received praise from Boston University
Chancellor John Silber, BMC
President and CEO Elaine Ullian,
Boston Mayor Thomas Menino,
and Westling.
From lefi: Boston Uniz/erSZtγ PγeSZdent
]on Westling, Senaioγ Kemedy, and
Dean A脇m Chobanian
Lauding the School’s commiト
ent to public health, COmmunity-
based medicine, and advancing
m ical research, Kennedy said he
will continue to support BUSM to
the best of his abilities. “One in
$10 from the National Institutes of
Health come  to Massachusetts -
and much of this funding supports
research at Boston University,” he
said. “Our goal over the coming
years in Congress is to double the
budget of the NIH. The potential
benefits are vast, and I am optimistic
that we will succeed. At Boston
University, hat support is an
pecially w se investment in the
future - for patients, for doctors,
dentists, nurSeS, and other providers,
for researchers, and for taxpayers -
and I intend to do all I can to see
that it is strengthened.’’
During the presentation,
Chobanian highlighted so皿e of
Kem dy,s legislative accomplish-
ments, Which have been of great
importance to biomedical research
and medical education. His achieve-
ments include being the original
sponsor of the Comprehensive Health
Manpower Act of 1971, Which assisted
medical schooIs in designing new pro-
grams responding to the demands of
the changlng health care environment;
being the original author of the
National Health Service Corps,
through which financially disadvan-
taged students attend medical school
in exchange for providing care for the
underserved in rural and urban areas
after they have completed their train-
ing; and supporting health care and
education l programs for minorities
and women.
$en tor Edu/aγd Kemedy
Silber praised Kemedy’s record in
Congress, Saying’∝Senator Kemedy
has been, for more than thirty years,
in a position to influence the passage
of health care legislation for all・
Additionally, he has been effective in
preventing the passage of legislation
that would have been harmful to
medical students, Public health, and
medical research. ’’
The ceremony marked the end
of a year of events celebrating the
sesqulCentennial milestone’including
the first Alumni Career Day, the
Ⅵ)men in Medicine Awards ceremony,
the Rebecca Lee 5K Road Race, the
Convocation, the gala, a PlanO
recital, a Cardiovascular Symposium
in honor of the twenty-fifth amiver-
sary of the Whitaker Cardiovascular
Institute at BUSM, an intemational
symposium on the brain, and numer-
ous other scientific conferences.
S T U D E N T P R O FI L E S
The student body at BUSM compri§e§ a number of outstandjng
individuaIs, Featured he「e are some of the talented students and
their varied inte「ests in scieれCe and medicine.
Nichoias Husれi, ’99
Nicholas Husni, Who will graduate
this month with a combined MD_
PhD degree, WaS invited to speak at
the thirty-fourth Amual Meeting of
the European Association for the
Study of Diabetes, in Barcelona,
Spain, last fall. He presented a por-
tion of his PhD thesis work on tumor
necrosis factor alpha and its effects
On Skin fibroblasts from patients
with diabetes.
``My fascination with the care-
fully orchestrated cascade of cellular
and biochemical events that culmi-
nate in the
WO und-he aling
PrOCeSS began on
my second day
Of pathoIogy
class, ’’reca11s
Husni. ``Not
being satisfied
With simply
memorizing the
Various stages, CytOkines, and cells
involved in healing by primary and
Secondary intention, I decided to
transfer into the MD-PhD curriculum
SO that I might design a course of
Study that would satisfy my curiosity.
I was able to find an ideal mentor in
Barbara Corkey, PhD, director of
Metabolic and Obesity Research, and
PrOfessor of medicine and biochem-
istry at BUSM, Who helped me to
Shape my clinically based questions
into hypotheses that could be investi-
gated by basic biochemical methods.
“Skin fibroblasts were obtained
from diabetic patients, and their
response to stimulation with inflam-
matory cytokines intimately invoIved
in the wound-healing process was
COmPared with cells taken from non-
diabetics. Interestingly, the cells from
the two donor groups varied
markedly in response to stimulation
With these cytokines, Which caused
Significant differences in agonist-
mediated calciu皿responses and in
basic calcium homeostasis itself.
A tissue culture medium designed
to mimic the metabolic environment
encountered in diabetic patients fur-
ther augmented the differences in
CytOkine response between controI
Subjects and diabetics. These findings
have implications for the vast array of
diabetic pathoIogies found through-
Out the natural history of the disease,
ranging from the inflammatory reac-
tion that destroys the pancreatic
islets in type l diabetes, tO the recal-
Citrant wound healing observed in
Older patients. ’’
Husni graduated from Boston
Co11ege magna cum laude in 1990,
and entered the combined degree
PrOgram in fa11 1991. During his
years here, he has served as a cellist
in the BUSM string ensemble and
won the Karin Grunebaum Research
Foundation Fellowship in 1996.
He plans a career as an academic
SurgeOn.
」ames §. Cheれ, ’02
Janes Chenis work as an MD-PhD
Candidate n the Department of
M crobioIogy a d in the Biomolecular
Pha macoIogy嶋aining Programs
helped him eam two awards from the
Pharmaceutical Research and Ma堪pr
facturers Foundation. He is both an
advanced predoctoral fallow and a
medical student research fellow He
carried ou  his research in the labora-
tory of Douglas FalleちPhD, MD,
director of the BUSM Cancer
Research CenteL
“I am studying a protein dubbed
RTNG3, Short for Really Interesting
New Gene 3,’’Chen reports. “As a
kinase, RTNG3 phosphorylates other
molecul s in the cell, thereby regulat-
ing their ctivity. Since it resides in
the nucleus, RENG3 probably can act
On a Class of cellular proteins called
tra皿scription factors, mOlecules that
re important in determining what
types of new proteins are made in
the cell. I deed, forcing cells to pro-
duce large amounts of RING3 actu-
a11y causes those cells to transfom,
Or become ne plastic, SuggeSting that
RING3 has an impact on proteins
that are important in directing cell
growth. In addition, RING3 is
activated by extrace11ular signals,
including interleukin-1 (IL-1), an
in血 mmatory cytokine. These obser-
Vations together suggest a potential
role for RING3 in the development
Of hyperproliferative inflammatory
disorder  such as atherosclerosis.
“My focus is on what controIs
RING3’s activity. By studying its reg-
ulation, I will be examining RTNG3,s
Part in inf ammatory signaling and
Will be investigating whe血er defects
in these sign ls can lead to the dys-
regulated prolif-
eratlOn Seen m
atherosclerotic
Plaques. My pre-
1iminary results
indicate that a
new class of
drngs, the
CSAIDs
(cytokine sup-
PreSSive anti-inflammatory drugs),
Can down-regulate the RTNG3 signaト
ing axis by i hibiting various MAP
kinase p thw ys, thus highlighting
POtential targ ts for intervention in
RING3-m di ted maladies. Intensive
investigation of these pathways for
IL-1 signaling will provide us with
SOme neW insight into inflammation
and atherosclerosis, With the poten-
tial for developing a whole new class
Of herapeutics. ”
Chen graduated from Stanford
University with a BS in 1992 and an
MS in 1993 (both in biological sci-
ences), the en ered the combined
degree program. His research
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has won other awards, including the
American Heart Association
Research Fellowship, 1997; American
Society of HematoIogy Research
Fellowship, 1997; Karin Grunebaum
Foundation Research Fellowship,
1996; and American Cancer Society
Foundation Summer Research
Fellowship, 1994.
Ma「garet S,しee, ’99
This academic year Margaret Lee,
’99, Who represented the student
body in a performance at the
Sesquicentemial Gala Ba11, has made
Significant moves toward building
her dreams of integrating cultures,
SCiences, and arts in medicine.
Lee was the 1999 winner of the
Leah J. Dickstein Award from the
Association of Wbmen Psychiatrists,
recognlZmg Creativity, energy, and
leadership.
As’a first-year medical student,
she cofounded the Creative Arts
Society (CAS) to
advance recogni-
tion of the heal「
mg POtential of
art and creativ-
ity. Tivo very suc-
CeSSful products
of CAS are the
Publication
W吻oγl and the
POPular Kick Back Kafe coffeehouse
event. A new proJeCt, the Arts-
Healthcare A11iance brings Boston
Medical Center faculty and staff and
Boston artists together for perfor-
mances at the hospital. “Music and
POetry have been central to my per-
SOnal development and well-being,,,
SayS Lee, ``so it is natural for me to
Want tO Share and encourage the
healing power of art as a medical
student and doctor.,,
When Lee graduated from MIT
in 1992, She had already gained sub-
Stantial experience in laser treatment
of tatoos at the MGH W別lman
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Laboratories of Photomedicine. She
has continued to develop her interest
in photomedicine and is currently
WOrking at the Department of
DermatoIogy lab, Studying the pro-
tective effects of thymine dimer
treatment in cell cultures from exoge-
nous oxidative damage, SuCh as
hydrogen peroxide solutions. She has
already begun work for a phD in
the Department of PathoIogy and
Laboratory Medicine.
Lee extended her fourth year of
medical school to study traditional
Chinese medicine in Sou血Korea,
Where she was bom. Although she
grew up in the United States, her
Korean heritage has been an impor-
tant part of her identity and extends to
her professional goals. She plans to
COmbine her studies in allopathic med-
icine with traditional Chinese medicine
and conduct research on altemative
and integrative therapeutics.
In her remarks at the Gala Ball
On October lO, Lee expressed her
COnfidence in the future: “From the
first class of twelve’150 years ago,
We have now grown to more than
600, COming from many back-
grounds and from a11 across this
great nation・ V(7e are informed, We
are prepared, and we are ambitious.
The courage and vision of these past
150 years are ours today as we carry
the tradition of leadership and excel-
lence into the next 150 years.・,
Eric R, First〇 °00
Botulinun toxin was once known
Only as a potent poison, but now it
is bringing relief to thousands of
Patients with a variety of neuromus-
Cular disord rs as a result of some vig-
OrO S reSearCh by Eric First, ’00.
First entered BUSM in fal1 1994,
having graduated magna cum laude
from Boston University,s MMEDIC
PrOgram. While an undergraduate,
he b gan a productive collaboration
With L. Bruce Pearce, PhD, nOW an
adjunct professor of phamacoIogy,
Characterizmg dinical preparations
Of CIostridium botulinum toxin, and
developing an assay to assess potency.
The team is also developing new a皿d
un que formulations of botulinum
toxin. “Billi nths of a gram of toxin
are injected into a muscle or muscles
affected by sp m, COntraCtion, Or
intractable pain,’’explains First.
“T is causes a localized, reVerSible
Paralysis through the inhibition of
acetylcholine release, Which restores
the muscle back to a near-nOr皿al
State. Since this is a localized injec-
tion, there are virtually no side
effect . The long duration of action
(months versus hours of standard
drugs) makes this a truly unique
treatment. Botulinum toxin was
approved in 1989 for the treatment
Of strabisimus (cross-eyeS). It is now
used in more than 125 different
indications, ranging from various
dystonias, eXCeSSive sweating, and
gastrointestinal sphincter disorders
to cosmetic wrinkle reduction and,
most recently, migraines.
“My research has focused on
developing new formulations of toxin
to increase the duration of action and
POtenCy, and therefore decrease血e
frequency of
mleCtions.
Current clinical
research focuses
on botulinum
toxin and
Pain-how the
toxin decreases
Pain signals.
``After my
frst year of medical school, I took
wo years offto continue my .も
research, Publ shing more than a
dozen papers ln JOumals such as T協
Laタ弓CeL In addition, I founded
Theratox Corporation’a COmPany
SPeCializing in botulinum toxin. Now
in my third yeaちI continue extensive
Clinic l research and publishing,
manage an Intemet site dedicated
S T U D E N TP R O F I L E S
exclusively to botulinum toxin
毎秒鋤boiulinum-tO諦n.nei), and
COntinue to pursue the business
aspects of my company.’’
Miche=e S, Hirsch, PhD, ’99
During her undergraduate experience
at the University of Califomia, Davis,
Michelle Hirsch became a teaching
assistant in anatomy. There she met
Hugh Patterson, MD, a 1977 gradu-
ate of BUSM,s
Division of
Graduate
Medical Sciences,
Who encouraged
her to seek a
doctorate in
anatomy here.
She entered
BUSM in fa11
1991. After eaming her doctorate in
anatomy and neurobioIogy in 1996,
she entered the medical curriculum
and will graduate in May 1999.
Hirsch,s research focuses on fetal
Skeletal development. “The fetal
Skeleton is a cartilaginous tissue,,,
She explains, ``composed of chondro-
CyteS SurrOunded by an extrace11ular
matrix. I was able to create a unlque
Organ Culture model that allowed
investigation of terminal chondrocyte
differentiation without disrupting the
cells from their natural enviro皿ment.
I determined that communication
With the extracellular matrix, SPeCifi-
Cally through integrin receptor slg-
naling, WaS important for this step m
development by allowing subsequent
Changes in the synthesis of many pro-
teins, including collagen molecules,
metalloproteinases, and the tissue of
metalloproteinase inhibitors. Changes
in these proteins have been shown to
be necessary, before replacement of
Cartilage by bone, in the developing
fetal skeleton.,,
Hirsch plans a career as an
anatomic pathoIogist in either surgl-
Cal or forensic pathoIogy.
Pedram SaIimpour, ’00
Pedram Salimpour is the only med-
ical student ever to have twice
received the American Co11ege of
Physicians’Medical Student Research
Award. Over the course of the past
four years, Salimpour,s research in
SeXual dysfunction has resulted in
numerOuS SClen-
t誼c publications
and several fel-
lowships, indud-
ing an AIpha
Omega AIpha
Medical Honor
Society Fellow-
Ship and several
educational
awards from phamaceutical industry
l aders. Additiona1獲y, he has been
interviewed a number of times in the
POPular press about his research pro-
jects・ This exposure has provided
the opportunity for him to present
PaPerS throughout the United States
and in Europe.
In the Department of UroIogy,
Salimpour led several projects,
including a study of the association
between lumbosacral disc disease and
impotence; the effects of compressive
fo ces on perineal contents; ereCtile
a皿d urinary problems in bicydists;
the correlation of body mass index
and erectile dysfunction; and a study
Of no e1 3-D imaging systems for use
in laparoscopic surgery. He has pre-
Sen ed the find ngs of these studies at
local, national, and intemational sci-
entific meetings and has succeeded
in conveying a clear message to an
interested public: “For years people
chought that sexual dysfunction was
PSyChoIogical. W〕rking with Dr.
Irwin Goldstein, PrOfessor of uroIogy,
BUSM, We’ve shown that it is the
result of physiological components:
bicycling, Cholesterol, drug interac輸
tions, and high body mass index.
These findings have had a remark-
able social impact. ’’
As an undergraduate at the
University of Califomia, Riverside,
Salimpour served as chairman of stu-
dent govemment and upon gradua-
tion was inducted as a member of the
Chancellor’s Honor Society. Later; he
eamed a master’s degree in pharma-
ceutical economics at UCLA. Before
medical school, Salimpour worked as
a lobbyist in Washington, DC, aS
Well as in advertismg in Los Angeles.
He continues his interest today as
a medical consultant to BBDO
Advertismg, amOng Whose accounts
is that of the British Health Service.
」anetta Cureton〇 °00
Janetta Cureton will enter the third
year clinical clerkships in a few
Weeks wi血a year’s experience as a
Congre sional Fellow in the US
H use of Repres ntatives.
Last spring she won a fellowship
through血e Congressional Black
Caucus Foundation. Later in the sum-
meちShe began her fd1owship in the
Office of Congressman EdoIphus
Tbwns (D-NY)-the ranking minor-
ity member of
the Human
R sources Sub-
committee of the
Govemment
Reform and
Oversight Com-
mi tee. As a
Congr ssional
Fellow, Cureton
used her strong science background
to conduct research and shape public
POlicy on the safety of the US blood
supply and t蹄e shortage of immuno-
globulins currently available. “It gives
you a di任erent perspective on the
issues,’’says Cureton. “I understand
the pr cess now, and see that a pro-
POSal might sound really good, but
When you apply it, it may not work.,,
D ring the recess and into the
new year, She spent time at the
N tional Cancer Institute in the
Office of Special Populations
Researc ・ “I’ve been doing some
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data analysis on the importance of
the underserved in clinical trials and
becoming familiar with the grants
process. Y⊃u COuld call it a lesson in
the politics of cancer.”
Cureton graduated from Clark
Atlanta University in 1996 with a
BA in biology and entered BUSM
through the Early Medical SchooI
Selection Program.
Seiene Parekh〇 °99
Selene Parekh will graduate this
spring as one of a new breed of
alumni: MDs with MBAs. For
Parekh, the MBA program was a nice
complement to the MD education-
teaching different teamwork ski11s,
and problem-based case evaluations
to reinforce cre-
ativity and
“thinking out-
side the box,’’
a ski11 useful in
both medicine
and business. αI
Plan to continue
my mVOlvement
with outcomes-
type research as a resident,’’says
Parekh. “As an attending physician,
I hope to add value to the hospital
and department I work with, uSing
business skills to acquire funding for
research from the private sector and
developing algorithms of care for
more efficient management. ’’
Parekh entered the Combined
BA-MD Program in 1991, and dur-
ing his undergraduate education
worked as a research assistant at
Massachusetts General Hospital’s
Department of Orthopedic Surgery.
He took time off between his second
and third years to work as a research
fellow in the MGH V(たIlman Laser
Center of Photomedicine.
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C, Charles Wen〇 °OO
C. Charles Wch, Who will graduate
from BUSM next sprmg, eamed his
BS from Boston University, magna
cum laude, in 1995. He then took
time off after completing the preclini-
cal years at BUSM to obtain an MBA
from the Boston University School of
Management.
“During my MBA study, I
leamed how medicine worked from
the business side, how medical orga-
nizations are currently structured,
and how the
medical system
has evolved into
what it is today.
I also leamed
management
echniques that
are widely
applicable to
e触ciency, OPera-
tions, quality management, and
information technology,’’he says.
“As I was completi皿g my MBA, I
accepted an intemship at Boston
Scientific Corporation to apply what
I,ve leamed from business school in a
practical setting. At Boston Scientific,
I worked in the uroIogy division
evaluating future markets, analyzing
comp titor positions, and implement-
ing new programs to improve data
gathering. ’’
Rishi P, Singh, ’01
Rishi Singh won first prlZe in the
basic science section of the NEH-
AAMC 1998 Research Poster Session
program held during the AMSA
Conference in Washington, DC.
The poster presented was titled
償What Rol  Do Ras and Rho
Proteins Play in Comeal W)und
Healing?’’and was based on research
conducted over the previous summer
in the laboratory of Vickery
Ti-inkaus-Randall, MD, an aSSOCiate
professor of ophthalmoIogy.
The award recognizes work
accomplished by Singh funded by the
Fight for Sight Research Fellowship
to examine comeal wound healing at
a molecular level. He has continued
his research e任orts this year as a
recIPlent Of the 1998-1999 Research
to Prevent Blindness Fellowship.
“Using confoca=aser scaming
microscopy, PrOtein separation and
purification, and antisense technoIogy,
my research elucidated the chain of
events that occurs after an ocular
injury,,, reports Singh. “Since the
comea is a highly imervated struc-
ture, this process is usually accompa-
nied with a great deal of pain and
discomfort. I have concluded from
my research that Ha-Ras proteins
play a major role in cellular migra-
tion after an ocular injury. This
knowledge can be used to enhance
the injury response by reducing the
pam and the complicating infections
that normally follow an ocular
injury, While also reducing the heal-
mg tlme neCeSSary for these wounds.
αThe method I,ve used for trans-
fecting cells is a novel drug delivery
system, and thus could be used to
deliver more of this helpful protein
to an injured eye. Moreover, this pro-
tein may play a major role in other
fields, SuCh as in
the healing of
skin after bums
or cuts. Through
my examination
of the biochemi-
cal and cellular
events following
wounding, I
hope to promote
repalr m COmeal disease and comeal
wounds. This year has glVen me
the opportunity to attend various
research seminars and conferences
so that I may share the results of my
work with others and leam about
other research being conducted in
OPhthalmoIogy. ’’
Singh entered Boston University’s
Combined BA-MD Program in 1993.
1999 DISTINGUISHED ALUMNUS AwARDS
Every year′ the AIumni Association and BUSM recognize the outstanding
accompiishments of three graduates" The honorees, through thejr determト
nation and insight′ have made impo巾ant contributions to medjciれe,
NEW APPOINTMENTS
K諾謹詩聖t。_
laryngoIogist, Who has most recently
focused his interest on ear and hearing
disorders in children and adults, Will
assume leadership of the Department
Of OtolaryngoIogy on July l.
He brings an expertise in evaluat-
ing patients with hereditary hearing
impalrment, aS
well as his
Surgical ski11s
for treating
cho獲esteatoma
and chronic ear
conditions. His
vision for
the depart-
ment includes
enhanced teach-
mg, reSearCh, and dinical service.
“ OtolaryngoIogy now incorpo-
rates many new technoIogies such as
use of lasers for surgery on vocal
COrds, a teChnique first developed at
BUSM,’’notes Grundfast.
“OtolaryngoIogy is a vibrant spe-
Cialty with an ever-eXPanding array
of imovative methods for diagnosis
and treatment. In fact, uSe Of the laser
to operate on the larynx was pio-
neered at the BUSM by Dr. M. Stuart
Strong, Who had been chairman of
the Department of OtolaryngoIogy
from 1956 to 1985. Tbday, OtOlaryn-
gologists use microscopes and tele-
SCOPeS tO OPerate in the eaちthe
larynx, and the sinuses. Computer-
guided systems are used for precise
localizing of instruments during
Surgery in the paranasal sinuses. New
technoIogy enables otolaryngoIogists
to alleviate snormg and sleep apnea
usmg a device in the office that
reduces the size of soft palate mus-
Cles. AIso, neW devices are being used
to perfuse medications directly to the
imer ear in order to alleviate symp-
toms of vertigo in some patients.
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“I want to develop a department
that is always moving forward and is
continually responsive to the needs of
physicians and patients at the SchooI
of Medicine and Boston Medical
Centeす’says Grundfast. ``The depart-
ment will have a personality: it will
be friendly, Caring, reSPOnSive, have
high energy, and be open to new
ideas. While continuing to pursue
my own area of interest in hearing
mpalment, I plan to expand basic
research programs investigating the
etioIogy of head and neck cancer and
Seek to identify the molecular mecha-
nism  involved in hereditary deafness.
I hope to work with collaborators at
BMC in developing outcomes research
PrOjects to monitor and continua11y
improve the efficacy of altemative
methods of managing patients with
otolaryngic disorders. ’’
Grundfast received his AB degree
from Johns Hopkins University and
MD degree from the State University
Of New Ybrk at Syracuse. After
intemship and residency trammg m
general su gery at血e New England
Medical Center in Boston and the
Sibley Memorial Hospital in
V(なshington, DC, he trained as a
resident in otolaryngology at BUSM
wit  M. Stuart Strong, MD, and
Charles Vaughn, MD. He then
COmPleted a fellowship in pediatric
OtOlaryngoIogy at the Children’s
Hospital of Pittsburgh before joining
the faculty at the George Wなshington
Unive sity SchooI of Medicine
a d accepting an appomtment aS
Chairman of the Department of
OtolaryngoIogy at the Children’s
National Medical CenteL After attain-
mg the rank of professor with tenure
a the G orge VAshington University
SchooI of Medicine, Grundfast moved
to G orgetown University Medical
Center; Where he currently serves as
professor and interim chairman of the
Department of OtolaryngoIogy.
In 1998, Grundfast received the
award for excellence in education
at Georgetown University Medical
Ce ter.
He spent a sabbatical year in
1989 working at the National
Institute on Deafness and Other
Communication Disorders at the
NIH, and he has published more
than on  hu dred articles on topICS
rangi g from the molecular genetics
Of he rmg disorders to the manage-
ment of ommon ear problems in
children. Grundfast’s many honors
and war s include the presidential
Citati n and the distinguished service
award of the American Academy
Of OtolaryngoIogy-Head and Neck
Surgery. He has been president of
the Society for EaちNose, and
丁hroat Advancements in Children;
t e American Society of Pediatric
Otola yngoIogy; and the Inter-
national Socie  for the History
Of OtolaryngoIogy. In 1995 he
was elected vice president of the
American Academy of Otolaryn-
goIogy-Head and Neck Surgery.
Grundfast has served as a member
Of several national advisory panels,
including the Alexander Graham
Be11 Association for the Deaf, and he
was a m mber of the panel convened
by the Agency for Health Care
Policy and Research (AHCPR) to
dev l p practice guidelines for man-
agement of otitis media in children.
In addition, he has been appointed
an associate examiner for the
American Board of OtolaryngoIogy,
and he serves on the editorial boards
Of num ous JOumals including the
]ourml of OタoIogy, the AγChiひes of
O laγγngOIogy-Head 4nd Necた
Sulgeγ)らand the Jnタermタioml
]ouγnal of Pediatric OiolaγγngOlogy
NEW SURGEONS JOIN BosTON UNIVERSITY
B聖霊器霊雷嵩
University Medical Center (BUMC)
has added to its roster four surgeons,
formerly of Beth Israel Deaconess
Medical Center and Harvard Med-
ical School. R. Amour Forse, MD,
PhD; Timothy Babineau, MD;
Stephen Sentovich, MD; and Peter
Burke, MD, joined BUMC as of
March l, 1999.
AIong with their medical center
POSitions, all four surgeons will hold
academic titles at Boston University
SchooI of Medicine. Their reputa-
tions as outstanding physicians, Sur-
geons, and academicians are well
known throughout the medical com-
munity and will advance the aca-
demic mission of the school.
Forse received both his MD
and PhD from McGill University in
Montreal, and completed his intem-
Ship and residency at Royal Victoria
Hospital in Montreal- SerVing as
Chief resident in surgery. He was a
research fellow and PhD candidate in
experimental surgery at McGill and a
research fellow in surgical metabo-
1ism at Columbia University College
Of Physicians and Surgeons in New
%rk. Most recently, Forse was an
associate professor of surgery at
Harvard Medical School. He special-
izes in the surgical treatment of
morbid obesity and gastrointestinal
disorders and has an active basic
research program in metabolism.
Babineau, Who specializes in
digestive disorders and minimally
invasive surgery, reCeived his MD
from the University of Massachusetts.
He completed his intemship and resi-
dency m general surgery at the New
England Deaconess Hospital, Where
he also served as a fellow in surgical
nutriti  and metabolism. Babineau
became an assistant professor of
Surge y at Harvard Medical School
in 1995 and served on the active staff
Of New England Baptist Hospital.
He also served as chief of surgery at
Vincor Hospital in Brighton.
Sentovich received his MD from
the University of Califomia, Los
Angeles SchooI of Medicine. He
COmPlet d his intemship and resi-
dency at the University of Califomia
Irvine Program in General Surgery,
wher  he served as chief reside皿t in
Surgery. Following a fellowship in
the fields of coIon and rectal surgery,
Sentovich joined the faculty in
Surgery a  Harvard Medical School
in 1994. He specializes in coIon and
rectal surgery, and his major research
interests include anorectal physiol-
Ogy, Pelvic floor disorders, and out-
COme/qual ty-Of-1ife issues.
Burke received his MD from
Ti血s University School of Medicine
and completed his intemship and
residency at the New England
Deaconess Hospital, SerVmg aS Chief
resident in surgery. He became an
assistant professor of surgery at
Harvard Medical School in 1995 and
SPeCializes in trauma surgery and
cri cal care. Burke,s research inter-
ests include gene regulation in injury
and molecular; metabolic, and
immunoIogica  responses to sepsIS
and injury.
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IN BRIEF
」oeI Aipe巾MD, PrOfessor of pedi-
atrics and public health, WaS elected
PreSident of the America皿Academy
of Pediatrics.
Robert Beazley, MD, PrOfessor of
Surgery and section chief of the
Department of Surgical Oncology
and Endocrinology, reCeived the 1998
Stanley L. Robbins Award for
Excellence in Teaching. This award
is glVen amually to an outstanding
educator at BUSM for his or her
excellence in teaching and devotion
to the students.
Dick A. 」, Brown, MD, director of
medical student education in the
Department of Obstetrics and
GynecoIogy, and associate clinical
professor of OB/GYN, reCeived the
1998 Frederick Jackson Faculty
Award for excellence in teaching
the clinical sciences.
PauI O-Bryan, PhD, aSSOCiate profes-
sor of physiology, reCeived the 1998
Thomas Robitscher Faculty Award
for his exce11ence in teaching the
PreClinical sciences.
しarry CuIpepper, MD, MPH, PrOfes-
sor and chairman of the Department
Of Family Medicine, WaS elected to
the Institute of Medicine.
Thomas Einhorn, MD, PrOfessor and
chairman of the Department of
O thopedic Surgery, reCeived the
Elizabeth Winston Lanier Award for
developing new strategleS tO treat
b ok n bones that have not healed
PrOPerly and for documenting the
omplex physioIogical process
invoIved in the normal healing of
fractures.
Ba「bara Ann GiIchrest, MD, PrOfessor
and chairwoman of the Department
of DermatoIogy, has been appointed
PreSident of the Society for Investi-
gative Dermatology (SID). The SID
has more than 2,500 members and
is the ma事Or reSOurCe Organization
for dermatology and skin bioIogy.
Additionally, Gilchrest was elected
to th  Insti ute of Medicine.
L輔an CaIdeira McMahon, MD, aSSO-
ciate clinical professor in the depart-
ments of Medicine and Pediatrics,
and program director of the Boston
omprehensive Sickle Cell Center at
BMC, reCeived the Distinguished
Community Award for Outstanding
and Dedicated Service to Sickle Cell
Patients and the Community from
the Community Sickle Cell Support
and Awareness Center of Boston.
Robert Meenan, MD, MPH, and
dean of SPH, WaS aPPOinted secre-
tary of the Arthritis Foundation.
I  this role, Meenan will lead more
than 600,000 volunteers and sta任
nationwide in the foundation,s mis-
sion o support research to find the
cure for and to prevent arthritis
and to mpr ve the quality of life
for those affected by disease.
」ohn Nob看e, MD, director of the
Primary Care Center and professor
of medicine, reCeived the 1999
Robe t J. Glaser Award for his
exceptional contributions to research
and education in the field of general-
ism i  med cine. This is the highest
award given by the Society of
General Intemal Medicine.
Domenic ;crenci, EdD, director
of the Educational Media Centeち
accepted the Intemational Telecon-
ferencing A sociation’s Excellence
Award for the ovel use of telecon-
ferencing in the audiovisual/multime-
dia category. The award recognized
BUSM’s project titled ``Intemational
Medical Education and Harmoni-
zation Program for Nuclear Accident
Preparedness.’’The project helped
train medical professionals from飾-
teen countries to handle aspects of a
radiation accident.
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